Dr. Anne Marie Manicone M.D.
Pulmonologist | Pulmonary Disease
1959 Ne Pacific St Seattle WA, 98195About
Dr. Anne Manicone practices Pulmonology in Seattle, WA. A pulmonologist is a physician who possesses specialized knowledge and skill in the diagnosis and treatment of pulmonary conditions and diseases. Dr. Manicone manages patients who need life support and mechanical ventilation, and is specially trained in diseases and conditions of the chest, particularly pneumonia, asthma, tuberculosis, emphysema, and complicated chest infections.
Education and Training
Univ of Wa Sch of Med, Seattle Wa MD
Jawaharlal Institute of Post Graduate Medicine Research, Pondicherry University 1998
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM- Pulmonary Disease- 2003
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Malignant peripheral neuroectodermal tumor (MPNET) of the kidney.
- [Pharyngeal and laryngeal hamartoma: case report].
- Matrix metalloproteinases as modulators of inflammation.
- Endometrial carcinoma: intraoperative evaluation of myometrial invasion. A prospective study.
- CXCR3 ligands contribute to Th1-induced inflammation but not to homing of Th1 cells into the lung.
- Role of the pulmonary epithelium and inflammatory signals in acute lung injury.
- Matrilysin (Matrix Metalloproteinase-7) regulates anti-inflammatory and antifibrotic pulmonary dendritic cells that express CD103 (alpha(E)beta(7)-integrin).
- Matrix metalloproteinase-28 deletion amplifies inflammatory and extracellular
- Pulmonary macrophage subpopulations in the induction and resolution of acute lung injury.
- Matrix metalloproteinase-28 deletion exacerbates cardiac dysfunction and rupture after myocardial infarction in mice by inhibiting M2 macrophage activation.
- MMP28 promotes macrophage polarization toward M2 cells and augments pulmonary fibrosis.
- Diet-induced obesity alters myeloid cell populations in naïve and injured lung.
- MEK1/2 Inhibition Promotes Macrophage Reparative Properties.
- Stat5 Is Required for CD103 Dendritic Cell and Alveolar Macrophage Development and Protection from Lung Injury.
- Pharmacologic inhibition of MEK1/2 reduces lung inflammation without impairing bacterial clearance in experimental pneumonia.
Fellowships
- UW - Division of Pulmonary/Critical Care
Dr. Anne Marie Manicone M.D.'s Practice location
Practice At 1959 Ne Pacific St
1959 Ne Pacific St -Seattle, WA 98195Get Direction
Dr. Anne Marie Manicone M.D.'s reviews
Write ReviewRecommended Articles
![]()
Pneumonia: Are There Multiple Types?What is pneumonia?Pneumonia is an acute lung infection that causes inflammation of the air sacs in either one or both lungs. The air sacs get filled with fluid or pus, making it difficult for the affected person to properly breathe. Individuals who have contracted the infection usually cough and...
![]()
Make-A-Wish Foundation Gives Teen with Cystic Fibrosis a Dream Come TrueThe Make-A-Wish Foundation is well known among those suffering from chronic illness and the population at large. The foundation has made many headlines for keeping true to its mission to “grant the wish of every child diagnosed with a life-threatening medical condition.” And that’s exactly...
![]()
Pneumonia in an Immunocompromised PatientPneumonia as a disease was once dreaded, since most of the cases would turn out to be fatal. This was many years ago, and with medical advances, times have changed. However, in some severe cases of pneumonia, especially in people with weakened immune systems, the disease can still be fatal. If the...
![]()
The Top 3 Myths About the Development of COPDPatients with Chronic Obstructive Pulmonary Disease (COPD) suffer from breathlessness. It is an illness that affects our lungs by simply inhibiting its normal functions. Chronic obstructive pulmonary disease is a progressive lung disease that has signs and symptoms of chronic bronchitis, which...
![]()
Firefighters from Around the World Take Steps Toward Cystic Fibrosis ResearchAs a firefighter, Wes Loucks received countless emergency phone calls throughout his 32 years of service for the Portland Fire and Rescue Bureau. After retiring, he received a personal call for help from his own family. His two grandsons were both born with cystic fibrosis (CF), a chronic genetic...
![]()
FDA Approves Orkambi to Treat Young Children with Cystic FibrosisOrkambi is an oral drug developed by Vertex Pharmaceuticals and approved by the United States Food and Drug Administration (FDA) for the treatment of cystic fibrosis (CF) in certain patient groups. It is the second drug to be approved for use in patients with CF, after Kalydeco. ...
Nearby Providers
![]()
Dr. Michael M. Bundesmann MD1959 Ne Pacific St. Seattle WA 98109![]()
Dr. Mary P Horan M.D.1560 N 115th St Seattle WA 98133![]()
Dr. Peter I-ping Chuang M.D.125 16TH AVE E SEATTLE WA 98112![]()
Dr. Ganesh Raghu MDUniversity Of Washington Medical Ctr Seattle WA 98195![]()
Dr. Peter Joseph Leary MD MSUw Medical Ctr Seattle WA 98195![]()
Jeffrey David Edelman OtherUniversity Of Washington Medical Ctr Seattle WA 98195
Nearest Hospitals
VIRGINIA MASON MEDICAL CENTERl
925 SENECA ST SEATTLE WA 98101GROUP HEALTH CENTRAL HOSPITALl
201 - 16TH AVENUE EAST SEATTLE WA 98112SEATTLE CHILDREN'S HOSPITALl
4800 SAND POINT WAY NE, PO BOX C-5371 SEATTLE WA 98105